Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Balk

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 26, 2005
Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapyPetros Athanassopoulos, Leonard M B Vaessen, Aggie H M M Balk, et al.
Transplantation|July 9, 2005
Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cellsCarla C Baan, Barbara J van der Mast, Mariska Klepper, et al.
Clinical and Experimental Immunology|July 28, 2005
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantationN M van Besouw, J M Zuijderwijk, L M B Vaessen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Cardiac sarcoidosis: Case-studies and a brief review of the literatureJ P Smedema, P E Zondervan, P van Hagen, et al.
Transplantation Proceedings|December 21, 2002
IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipientsC C Baan, A H M M Balk, A J van der Plas, et al.
European Journal of Heart Failure|August 20, 2005
Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxisDominic A M J Theuns, Andrew S Thornton, A Peter J Klootwijk, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptorMarike Wabbijn, Aggie H M M Balk, Ron T van Domburg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.
Transplantation|January 2, 2007
The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantationJacqueline van de Wetering, Charlotte H E Weimar, Aggie H M M Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2003
Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal studyHester A de Groot-Kruseman, Wendy M Mol, Hubert G M Niesters, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 26, 2005
Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapyPetros Athanassopoulos, Leonard M B Vaessen, Aggie H M M Balk, et al.
Transplantation|July 9, 2005
Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cellsCarla C Baan, Barbara J van der Mast, Mariska Klepper, et al.
Clinical and Experimental Immunology|July 28, 2005
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantationN M van Besouw, J M Zuijderwijk, L M B Vaessen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Cardiac sarcoidosis: Case-studies and a brief review of the literatureJ P Smedema, P E Zondervan, P van Hagen, et al.
Transplantation Proceedings|December 21, 2002
IL-15R alpha-chain expression during anti-CD25 treatment of cardiac allograft recipientsC C Baan, A H M M Balk, A J van der Plas, et al.
European Journal of Heart Failure|August 20, 2005
Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxisDominic A M J Theuns, Andrew S Thornton, A Peter J Klootwijk, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptorMarike Wabbijn, Aggie H M M Balk, Ron T van Domburg, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.
Transplantation|January 2, 2007
The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantationJacqueline van de Wetering, Charlotte H E Weimar, Aggie H M M Balk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 25, 2003
Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal studyHester A de Groot-Kruseman, Wendy M Mol, Hubert G M Niesters, et al.
Pageof 7